Medindia LOGIN REGISTER
Medindia

Drug Safety Labeling Changes - APRIL 2013

Food and Drug Administration (FDA) announces important safety label changes for prescription drugs almost every month. By implementing the label changes the FDA warns a physician of new side- effects, adverse reactions, contra-indications and precautions necessary for a drug. This information is important for safe practice of medicine.

Key to Label Sections

  • C - Contraindications
  • W - Warnings
  • P - Precautions
  • AR - Adverse Reactions
Drug Name Sections Modified
C W P AR
Histrelin Acetate - Subcutaneous Implant
Adapalene - lotion
Alendronate - Effervescent Tablets
Alendronate - Tablets and Oral Solution
Belatacept - Intravenous Injection
Benztropine - Injection
Candesartan - Tablets
Cyclobenzaprine -Tablets
Dabigatran - Capsules
Doripenem - for Injection
Dutasteride and Tamsulosin - Capsules
Emtricitabine - Capsulests and Oral Solution
Etidronate - Tablets
Fidaxomicin - Tablets
Golimumab - Injection
Histrelin Acetate - Subcutaneous Implant
Ibandronate - Injection
Ibandronate - Tablets
Lacosamide - Tablets, Injection and Oral Solution
Laronidase - solution for intravenous infusion
Lomitapide - Capsules
Quetiapine -Tablets
Quetiapine- Extended Release Tablets
Quinine - Capsules
Risedronate - Tablets
Telaprevir - Film Coated Tablets
Tocilizumab Injection
Treprostinil - Inhalation Solution
Ustekinumab - Injection
Zaleplon -Capsules
Zolpidem - Sublingual Tablets
Zolpidem - Tablets
Zolpidem- Extended Release Tablets

2016 - Monthly Summary Report for Drug Label Changes

2015 - Monthly Summary Report for Drug Label Changes

2014 - Monthly Summary Report for Drug Label Changes

2013 - Monthly Summary Report for Drug Label Changes

2012 - Monthly Summary Report for Drug Label Changes

Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Get Health and Wellness Secrets from Our Engaging eBooks
Stay Connected
Available on the Android Market Available on the App Store